Serdexmethylphenidate for treatment of idiopathic hypersomnia
AssigneeZevra Therapeutics, Inc.
InventorsSven Guenther, Travis Mickle, Rene Braeckman, Guochen Chi
Life of this patent
Estimating the term…
Abstract
The present technology relates to a method of treating sleep disorders in a patient, the method comprising: administering to the patient before bedtime a composition comprising a therapeutically effective amount of a conjugate of d-methylphenidate having a structure of Formula I or a pharmaceutically acceptable salt thereof, wherein the composition comprising the conjugate of d-methylphenidate is administered about 0-3 hours before the bedtime of the patient.
Claims28
A method of treating Idiopathic Hypersomnia in a patient, the method comprising:
- administering to the patient in need thereof before bedtime a composition comprising a therapeutically effective amount of a conjugate of d-methylphenidate having a structure of Formula I:
- or a pharmaceutically acceptable salt thereof,
- wherein the composition comprising the conjugate of d-methylphenidate is administered about 0-3 hours before the bedtime of the patient.
(canceled)
(canceled)
18-22. (canceled)
(canceled)
(canceled)
(canceled)
A method of treating Excessive Daytime Sleepiness in a patient, the method comprising:
- administering to the patient in need thereof before bedtime a composition comprising a therapeutically effective amount of a conjugate of d-methylphenidate having a structure of Formula I:
- or a pharmaceutically acceptable salt thereof,
- wherein the composition comprising the conjugate of d-methylphenidate is administered about 0-3 hours before the bedtime of the patient.
-51. (canceled)
A method of treating Sleep Inertia in a patient, the method comprising:
- administering to the patient in need thereof before bedtime a composition comprising a therapeutically effective amount of a conjugate of d-methylphenidate having a structure of Formula I:
- or a pharmaceutically acceptable salt thereof,
- wherein the composition comprising the conjugate of d-methylphenidate is administered about 0-3 hours before the bedtime of the patient.
53-189. (canceled)
Dependencies are inferred from the claim text.